These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
267 related articles for article (PubMed ID: 26268697)
1. Bilateral breast cancer, synchronous and metachronous; differences and outcome. Jobsen JJ; van der Palen J; Ong F; Riemersma S; Struikmans H Breast Cancer Res Treat; 2015 Sep; 153(2):277-83. PubMed ID: 26268697 [TBL] [Abstract][Full Text] [Related]
2. The prognostic comparison among unilateral, bilateral, synchronous bilateral, and metachronous bilateral breast cancer: A meta-analysis of studies from recent decade (2008-2018). Pan B; Xu Y; Zhou YD; Yao R; Wu HW; Zhu QL; Wang CJ; Mao F; Lin Y; Shen SJ; Sun Q Cancer Med; 2019 Jun; 8(6):2908-2918. PubMed ID: 31038845 [TBL] [Abstract][Full Text] [Related]
3. Bilateral Breast Cancer After Multimodality Treatment: A Report of Clinical Outcomes in an Asian Population. Wadasadawala T; Lewis S; Parmar V; Budrukkar A; Gupta S; Nair N; Shet T; Badwe R; Sarin R Clin Breast Cancer; 2018 Aug; 18(4):e727-e737. PubMed ID: 29254601 [TBL] [Abstract][Full Text] [Related]
4. A Retrospective Study on the Clinicopathologic Characteristics and Outcomes of 179 Cases of Synchronous and Metachronous Bilateral Breast Cancer in China. Jia H; Zheng Y; Wang P; Wei Z; Li X; Fu G; Wang C Clin Breast Cancer; 2022 Apr; 22(3):e341-e349. PubMed ID: 34728164 [TBL] [Abstract][Full Text] [Related]
5. Properties of Synchronous Versus Metachronous Bilateral Breast Carcinoma with Long Time Follow Up. Eliyatkin N; Zengel B; Yagci A; Comut E; Postaci H; Uslu A; Aktas S Asian Pac J Cancer Prev; 2015; 16(12):4921-6. PubMed ID: 26163616 [TBL] [Abstract][Full Text] [Related]
6. Association of molecular subtype concordance and survival outcome in synchronous and metachronous bilateral breast cancer. Ding S; Sun X; Lu S; Wang Z; Chen X; Shen K Breast; 2021 Jun; 57():71-79. PubMed ID: 33774461 [TBL] [Abstract][Full Text] [Related]
7. Efficacy of Breast Conservation Therapy in Early Stage Bilateral Breast Cancer. Lee MM; Heimann R; Powers C; Weichselbaum RR; Chen LM Breast J; 1999 Jan; 5(1):36-41. PubMed ID: 11348254 [TBL] [Abstract][Full Text] [Related]
8. Comparison of prognosis and clinical features between synchronous bilateral and unilateral breast cancers. Karakas Y; Kertmen N; Lacin S; Aslan A; Demir M; Ates O; Aksoy S; Altundag K J BUON; 2017; 22(3):623-627. PubMed ID: 28730766 [TBL] [Abstract][Full Text] [Related]
9. Clinicopathological features and prognosis of bilateral breast cancer: a single-center cohort study based on Chinese data. Hong C; Zheng Y; Geng R; Hu H; Zhong Y; Guan Q; Zhang Y; Li X Ann Transl Med; 2022 Jul; 10(13):742. PubMed ID: 35957718 [TBL] [Abstract][Full Text] [Related]
10. Synchronous and metachronous bilateral breast cancer: clinicopathologic characteristics and prognostic outcomes. Mruthyunjayappa S; Zhang K; Zhang L; Eltoum IA; Siegal GP; Wei S Hum Pathol; 2019 Oct; 92():1-9. PubMed ID: 31351153 [TBL] [Abstract][Full Text] [Related]
11. Are synchronous and metachronous bilateral breast cancers different? An immunohistochemical analysis focused on cell cycle regulation. Senkus E; Szade J; Pieczyńska B; Kunc M; Pliszka A; Jassem J Histol Histopathol; 2018 Jan; 33(1):55-64. PubMed ID: 28276034 [TBL] [Abstract][Full Text] [Related]
12. The prognosis of synchronous and metachronous bilateral breast cancer in Chinese patients. Liang X; Li D; Geng W; Cao X; Xiao C Tumour Biol; 2013 Apr; 34(2):995-1004. PubMed ID: 23296702 [TBL] [Abstract][Full Text] [Related]
13. Racial and Ethnic Disparities in Synchronous and Metachronous Bilateral Breast Cancer. Hewitt DB; Li Y; Bhattacharyya O; Fisher JL; Stover D; Obeng-Gyasi S J Racial Ethn Health Disparities; 2023 Jun; 10(3):1035-1046. PubMed ID: 35386052 [TBL] [Abstract][Full Text] [Related]
14. Bilateral breast cancer in China: A 10-year single-center retrospective study (2006-2016). Jiang H; Zhang R; Liu X; Ran R; Zhang J; Liu Y; Gui X; Chen Y; Li K; Shao B; Yan Y; Liang X; Song G; Di L; Li H Cancer Med; 2021 Sep; 10(17):6089-6098. PubMed ID: 34346560 [TBL] [Abstract][Full Text] [Related]
15. Synchronous and metachronous bilateral breast cancer among women with a history of lobular carcinoma in situ. Mallory MA; Whiting K; Park A; Gönen M; Gilbert E; King TA; Pilewskie ML Breast Cancer Res Treat; 2022 Jul; 194(1):137-148. PubMed ID: 35488092 [TBL] [Abstract][Full Text] [Related]
16. National trends of synchronous bilateral breast cancer incidence in the United States. Sakai T; Ozkurt E; DeSantis S; Wong SM; Rosenbaum L; Zheng H; Golshan M Breast Cancer Res Treat; 2019 Nov; 178(1):161-167. PubMed ID: 31325072 [TBL] [Abstract][Full Text] [Related]
17. Bilateral breast cancers in an Asian population, and a comparison between synchronous and metachronous tumours. Sim Y; Tan VKM; Sidek NAB; Chia DKA; Tan BKT; Madhukumar P; Yong WS; Wong CY; Ong KW ANZ J Surg; 2018 Oct; 88(10):982-987. PubMed ID: 30141242 [TBL] [Abstract][Full Text] [Related]
18. Synchronous bilateral breast cancer: a nationwide study on histopathology and etiology. Mejdahl MK; Wohlfahrt J; Holm M; Knoop AS; Tjønneland A; Melbye M; Kroman N; Balslev E Breast Cancer Res Treat; 2020 Jul; 182(1):229-238. PubMed ID: 32441019 [TBL] [Abstract][Full Text] [Related]
19. Synchronous, bilateral breast cancer: prognostic value and incidence. Jobsen JJ; van der Palen J; Ong F; Meerwaldt JH Breast; 2003 Apr; 12(2):83-8. PubMed ID: 14659335 [TBL] [Abstract][Full Text] [Related]
20. Clinicopathological Characteristics, Treatment and Outcome of 123 Patients with Synchronous or Metachronous Bilateral Breast Cancer in a Swiss Institutional Retrospective Series. Huber A; Seidler SJ; Huber DE Eur J Breast Health; 2020 Apr; 16(2):129-136. PubMed ID: 32285035 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]